DUBLIN–(BUSINESS WIRE)–The “Global
DNA Vaccine Market Outlook 2025” report has been added to ResearchAndMarkets.com’s
Several DNA vaccines are currently in clinical trials which are expected
to get approval soon. The industry has garnered the interest of
investors with funds pouring in from industry over and above development
funding provided by the government. The rise in R&D activities in the
industry is anticipated to propel the growth of the market.
Global DNA Vaccine Market Outlook 2025 provides an
in-depth analysis of the current scenario, the detailed market outlook
of the global DNA vaccine market overall as well as across various
geographies. Regional analysis is done across major markets in North
America, Europe, and the Asia Pacific.
The report provides comprehensive coverage on major industry drivers,
restraints, and their impact on market growth during the forecast
period. Furthermore, the study encompasses various market-specific
growth opportunities in global DNA vaccine market.
Major industry players operating in the global DNA vaccine market
include Novartis International, Merck & Co, GlaxoSmithKline, Sanofi
Pasteur, Pfizer, Astellas Pharma, Dendreon Corporation, among others.
These players are profiled herein based on attributes such as business
overview, product segments, and financial analysis. It also compiles the
performance comparison of the aforementioned companies and other leading
companies in the segment based on various parameters in the competitive
- North America
- Asia Pacific
- Novartis International AG
- Merck & Co. Inc.
- GlaxoSmithKline PLC
- Sanofi Pasteur S.A.
- Pfizer Inc.
- Astellas Pharma
- Dendreon Corporation
Key Topics Covered
1. Executive Summary
2. Research Methodology
3. DNA Vaccines
3.2.1 History of DNA Vaccine
3.2.2 Components of Plasmid DNA Vaccine
3.3 DNA Vaccine Mechanism
3.4 DNA Vaccine Delivery Methods
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by End-User
4.2.2 Market Share by Clinical Trials
4.2.3 Market Share by Region
5. Regional Analysis
5.1 North America
5.3 Asia Pacific
6. Market Dynamics
6.1 Industry Trends & Developments
6.1.1 DNA Vaccine Clinical Pipeline
6.1.2 Mergers & Acquisitions
6.1.3 Investments in the Industry
6.2 Growth Drivers
6.2.1 Higher Incidences of Infectious Diseases
6.2.2 Increasing Adoption in Animal Healthcare
6.2.3 Growing Demand for Novel Vaccines
6.2.4 Advantages over Conventional Vaccines
6.3.1 Ambiguous Regulatory System
6.3.2 Less Market Penetration
6.3.3 Incompatibility with Other Vaccines
7. Competitive Landscape
8. Company Profiles
8.1 Novartis International AG
8.2 Merck & Co. Inc.
8.3 GlaxoSmithKline PLC
8.4 Sanofi Pasteur S.A.
8.5 Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/r/svlybd
Laura Wood, Senior Press Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900